Wednesday, 26 August 2026European Markets

VOW Stock Jump On Wednesday, Outperforms Market

Loading stream...

(VIANEWS) - The Market ended the session with VOW (VOW.OL) rising 9.91% to kr7.43 on Wednesday while Oslo Børs Benchmark Index_GI dropped 0.1% to kr1,274.04.

VOW's last close was kr6.76, 68.44% under its 52-week high of kr21.42.

About VOW

Vow ASA, together with its subsidiaries, produces, delivers, and maintains systems for processing and purifying wastewater, food waste, solid waste, and bio sludge in Norway, France, Poland, the United States, and Italy. It operates in three segments: Projects Cruise, Aftersales, and Landbased. The Projects Cruise segment delivers ship systems to shipyards for newbuild constructions, which include advanced wastewater purification, waste management, and food waste processing; and advanced systems to shipowners for ships. The Aftersales segment provides spare parts and consumables; chemicals; and tailor-made service and maintenance programs. The Landbased segment offers Biogreen, a patented pyrolysis process for converting biomass, plastics, and waste into energy; Safesteril, a patented sterilisation process for food and pharmaceutical ingredients; and industrial robotics solutions, including robotic systems for waste recycling processes. This segment also develops, designs, and fabricates industrial furnaces and equipment for heat treatment processes. The company serves cruise, aquaculture, and landbased industries, as well as utilities. It has a strategic partnership agreement with Repsol, S.A. to explore applications and solutions to produce clean and renewable energy for CO2 emission reduction; European Tyre Enterprise Ltd. to develop a modularised and industrial solutions, and value chain to turn end-of-life tires into raw material and renewable energy; GRTgaz to produce a demo plant built to confirm that CO2 neutral pyrolysis gas can replace fossil gas in the European gas grid; SAS IMPROVE to develop technological solutions for the farm to fork valorisation of future proteins; and Imtech Steri's Biosteam to offer a range of ingredient sterilisation solutions and services. The company was formerly known as Scanship Holding ASA and changed its name to VOW ASA in January 2020. Vow ASA was founded in 2011 and is headquartered in Lysaker, Norway.

Earnings Per Share

As for profitability, VOW has a trailing twelve months EPS of kr0.05.

PE Ratio

VOW has a trailing twelve months price to earnings ratio of 148.6. Meaning, the purchaser of the share is investing kr148.6 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1.13%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 12.2%, now sitting on 831.6M for the twelve trailing months.

Volatility

VOW's last week, last month's, and last quarter's current intraday variation average was a negative 12.33%, a negative 2.75%, and a positive 2.71%.

VOW's highest amplitude of average volatility was 12.33% (last week), 3.73% (last month), and 2.71% (last quarter).

Yearly Top and Bottom Value

VOW's stock is valued at kr7.43 at 21:33 EST, way under its 52-week low of kr9.15.

More news about VOW (VOW.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com